CONTERA PHARMA A/S: Financial statements 2016
CVR: 33062214
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
CONTERA PHARMA A/S (CVR 33062214) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 3,107,817 and a net result of DKK 866,364 compared with DKK -1,083,182 the year before. That is an increase of 597.9% compared with the year before. Equity in the 2016 report amounted to DKK 1,466,894. The solvency ratio was 89%.
- Gross Profit
- DKK 3,107,817
- Profit/Loss
- DKK 866,364
- Equity
- DKK 1,466,894
- Total Assets
- DKK 1,648,349
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 3.1 mio. | 866 t. | 1.5 mio. | - |
| 2015 | - | 445 t. | -1.1 mio. | 601 t. | - |
| 2014 | - | -126 t. | -3.2 mio. | 1.7 mio. | - |
| 2013 | - | -3.4 mio. | -4.7 mio. | 1.7 mio. | - |
| 2012 | - | -3.7 mio. | -4.2 mio. | 6.4 mio. | - |
Official annual report
Find more companies like CONTERA PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
CONTERA PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 445,321, and the net result was DKK -1,083,182.
About CONTERA PHARMA A/S
CONTERA PHARMA A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CONTERA PHARMA ApS and CONCIT PHARMA ApS. The management consists of Thomas Nikolaj Sager. The board consists of Jae Young Lee (chair), Jee Hun Kim, Paul Ejnar Gremaud Kristjansen and Thomas Nikolaj Sager. The company is owned by Bukwang Pharmaceutical Co., Ltd. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 20,632,306 and a net result of DKK -4,783,781 compared with DKK -69,213,744 the year before. Equity in the 2025 report amounted to DKK 79,471,802.